The pharmaceutical industry has undergone significant transformation, evolving from treating acute conditions to focusing on chronic diseases and personalized medicine. Medical Affairs (MA) has emerged as a critical function bridging Research & Development (R&D), commercial teams, and healthcare professionals (HCPs). Initially, MA played a supporting role in post-marketing activities but has since expanded to encompass strategic decision-making throughout the product lifecycle. The increasing complexity of drug development, regulatory requirements, and real-world evidence (RWE) demands a scientific, ethical, and data-driven approach. MA now serves as the scientific backbone of pharmaceutical organizations, ensuring compliance and aligning treatments with patient and healthcare system needs.